Monica E Mazda

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The development of progressive multifocal leukoencephalopathy (PML) in patients treated with natalizumab is a well-known potential risk. Diagnosis of PML can be confounded in patients with multiple sclerosis (MS) if new demyelinating lesions develop, and the sensitivity of existing diagnostic tests is less than ideal. In the case presented here, four(More)
  • 1